Testing two kinds of MRI scans to find problems in the brain and spinal cord
Original title: Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is a middle stage test in people to see how well these scans work.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study tests whether two MRI scans can help doctors find and understand problems in the brain and spinal cord.
Who this trial is for. This trial is for people who have something abnormal in the brain or spinal cord. It tests how well MRI scans that use contrast dye: A liquid put into a vein before some scans. It makes certain tissues stand out, which helps show where a tumor is. It does not always show the whole of it. See the glossary and ferumoxytol help find and diagnose these problems.
Where it stands. The trial is looking at how well these two scans work to find problems. The answer is not in yet. The trial has not reported results.
What this means, and what it doesn't
What it could mean: Better scans might one day help doctors see brain and spinal cord problems more clearly. If you think you might fit, you could ask your care team about this trial.
What it doesn't mean: This is a test, not a proven way to find or treat a tumor. Being in a trial does not promise that it will help you. It is not a cure, and it does not treat the tumor itself.
Source: ClinicalTrials.gov, September 14, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.